Fine Industries is a leading contract manufacturer of high-quality products and solutions used in the chemical and life sciences industries. The company develops and manufactures complex intermediates and actives for its agrochemical and pharma clients, as well as a broad portfolio of solutions for the chemicals market.
Following five years of growth, the business was backed by NorthEdge in November 2013. NorthEdge was attracted to Fine Industries because of its strong market position and its reputation for excellent customer service and quality control. The business operates in a global market and serves a range of international blue chip customers.
NorthEdge Capital completed the sale of chemicals manufacturer Fine Industries Limited to Chinese-listed life sciences company Lianhe Chemical Technology Company Limited (Lianhetech) in April 2017. The transaction was NorthEdge’s fourth exit following the sale of Sumo Digital and IPOs of Accrol Group Holdings and Ramsdens Financial, and represents a 2.5x return on investment for NorthEdge Capital Fund I.
Ray Stenton, Managing Partner at NorthEdge, said: “This deal represents a fantastic return on investment for NorthEdge Capital Fund I. It is pleasing to see our portfolio companies being recognised internationally, and it is testament to the strong progress Fine Industries has made in the years since our investment that it has attracted interest from Lianhetech – a key player in the chemicals sector.”
Maggie Wang Board Chair and CEO at Lianhetech, said: “The acquisition provides the geographic presence, capability and expertise needed to develop new products and better utilise Lianhetech’s state-of-the-art technologies for our customers around the world. I am delighted to welcome the Fine Industries Group, its employees, expertise and capabilities into our company. Together we will strengthen our technical solutions and product offerings to our global customer base.”